Skip to content

Evaluation of transcutaneous electrical nerve stimulation in patients with cancer pain under palliative care who make chronic use of morphine

Evaluation of low and high frequency transcutaneous electrical nerve stimulation in patients with cancer pain under palliative care who make chronic use of morphine: experimental study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-5c23n4p
Enrollment
Unknown
Registered
2024-01-12
Start date
2024-01-30
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer pain

Interventions

Patients will be randomized through the website randomization.com, by a researcher not involved in the evaluation and intervention, and divided into group A (35 participants), which will receive high-
E02.331.800

Sponsors

Fundação Pio XII - Hospital de Amor de Barretos
Lead Sponsor
Fundação Pio XII - Hospital de Amor de Barretos
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients at least 18 years old; of both sexes; who have neuropathic cancer pain assessed by the Questionnaire for the Diagnosis of Neuropathic Pain (DN-4), Nociceptive or Mixed, with pain intensity classified by Scale Visual Numerical greater than or equal to 4; who make chronic use of morphine, characterized as use more than three months ago

Exclusion criteria

Exclusion criteria: Patients who present inability to communicate verbal or cognitive inability to perform Transcutaneous Electrical Nerve Stimulation (TENS) and non-tolerance within the time proposed therapy; patients with cardiac conditions such as cardiac pacemakers and cardiac arrhythmias; metallic implants at the site of electrode placement; epilepsy; dermatologic conditions, or skin lesions at the location of the pain that makes it impossible to attach the electrode and history of allergies to conductive gel componentes

Design outcomes

Primary

MeasureTime frame
Evaluate the effect of high-frequency and low-frequency Transcutaneous Electrical Nerve Stimulation on pain control oncology of patients in palliative care with chronic use of morphine

Secondary

MeasureTime frame
Characterize the profile of patients with cancer pain in palliative care in chronic morphine use;Compare the intensity and aspects of pain in the pre- and post-intervention moments between the groups that will receive high and low frequency Transcutaneous Electrical Nerve Stimulation;Correlate morphine dosage and rescues in the pre and post moments intervention between the groups that will receive high and low frequency Transcutaneous Electrical Nerve Stimulation

Countries

Brazil

Contacts

Public ContactElizabeth Barichello

Universidade Federal do Triângulo Mineiro

elizabeth.barichello@uftm.edu.br+55 34 991740297

Outcome results

None listed

Source: REBEC (via WHO ICTRP)